The use of financial incentives in promoting smoking cessation

Preventive Medicine

Volumn 55, Issue SUPPL., 2012, Pages

  Sigmon, Stacey C ^a   Patrick, Mollie E ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Behavioral; Contingency management; Incentives; Nicotine; Reinforcement; Smoking cessation; Tobacco

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; COTININE; ILLICIT DRUG; NICOTINE; VARENICLINE;

ADOLESCENT SMOKING; BIOLOGICAL MONITORING; BREATH ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; FINANCIAL MANAGEMENT; GROUPS BY AGE; HEALTH CARE COST; HEALTH PROMOTION; HUMAN; INFORMATION TECHNOLOGY; LUNG DISEASE; MENTAL DISEASE; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; PUBLICATION; REVIEW; REWARD; SMOKING CESSATION; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

FINANCIAL SUPPORT; HEALTH PROMOTION; HUMANS; MOTIVATION; REWARD; SMOKING CESSATION; UNITED STATES;

EID: 84867231974     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2012.04.007     Document Type: Review

References (164)

1. Agusti A.G. Systemic effects of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005, 2:367-370.
2. Ahluwalia J.S., Harris K.J., Catley D., Okuyemi K.S., Mayo M.S. Sustained release bupropion for smoking cessation in African Americans. JAMA 2002, 288:468-474.
3. Alessi S.M., Badger G.J., Higgins S.T. An experimental examination of the initial weeks of abstinence in cigarette smokers. Exp. Clin. Psychopharmacol. 2004, 12:276-287.
4. Alessi S.M., Petry N.M., Urso J. Contingency management promotes smoking reductions in residential substance abuse patients. J. Appl. Behav. Anal. 2008, 41:617-622.
5. Amass L., Kamien J. A tale of two cities: financing two voucher programs for substance abusers through community donations. Exp. Clin. Psychopharmacol. 2004, 12:147-155.
6. Amass L., Kamien J.B. Funding contingency management in community treatment clinics: use of community donations and clinic rebates. Contingency Management in Substance Abuse Treatment 2008, 280-297. The Guilford Press, New York, NY. S.T. Higgins, K. Silverman, S.H. Heil (Eds.).
7. Amass L., Bickel W.K., Crean J., Higgins S.T., Badger G.J. Preferences for clinic privileges, retail items and social activities in an outpatient buprenorphine treatment program. J. Subst. Abuse Treat. 1996, 13:43-49.
8. American Cancer Society Stronger Anti-Smoking Laws Could Save Millions of Lives and Billions of Dollars 2011, American Cancer Society, Atlanta.
9. Benowitz N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev. 1996, 18:188-204.
10. Brigham J., Henningfield J.E., Stitzer M.L. Smoking relapse: a review. Int. J. Addict. 1991, 25:1239-1255.
11. Cahill K., Perera R. Quit and Win contests for smoking cessation. Cochrane Database Syst. Rev. 2008, CD004986.
12. Cahill K., Perera R. Competitions and incentives for smoking cessation. Cochrane Database Syst. Rev. 2011, CD004307.
13. Cahill K., Moher M., Lancaster T. Workplace interventions for smoking cessation. Cochrane Database Syst. Rev. 2008, CD003440.
14. Cavallo D.A., Cooney J.L., Duhig A.M., Smith A.E., Liss T.B., McFetridge A.K., Babuscio T., Nich C., Carroll K.M., Rounsaville B.J., Krishnan-Sarin S. Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats. Am. J. Addict. 2007, 16:468-474.
15. Cavallo D.A., Nich C., Schepis T.S., et al. Preliminary examination of adolescent spending in a contingency management based smoking cessation program. J. Child Adolesc. Subst. Abuse 2010, 19:335-342.
16. Centers for Disease Control Smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 2000-2004. Morb. Mortal. Wkly. Rep. 2008, 57:1226-1228.
17. Centers for Disease Control Tobacco use among middle and high school students - United States, 2000-2009. Morb. Mortal. Wkly. Rep. 2010, 59:1063-1068.
18. Chornock W.M., Stitzer M.L., Gross J., Leischow S. Experimental model of smoking re-exposure: effects on relapse. Psychopharmacology (Berl) 1992, 108:495-500.
19. Clemmey P., Brooner R., Chutuape M.A., Kidorf M., Stitzer M. Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend. 1997, 44:123-132.
20. Corby E.A., Roll J.M., Ledgerwood D.M., Schuster C.R. Contingency management interventions for treating adolescents: a feasibility study. Exp. Clin. Psychopharmacol. 2000, 8:371-376.
21. Correia C.J., Benson T.A. The use of contingency management to reduce cigarette smoking among college students. Exp. Clin. Psychopharmacol. 2006, 14:171-179.
22. Crowley T.J., MacDonald M.J., Zerbe G.O., Petty T.L. Reinforcing breath carbon monoxide reductions in chronic obstructive pulmonary disease. Drug Alcohol Depend. 1991, 29:47-62.
23. Crowley T.J., Macdonald M.J., Walter M.I. Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients. Psychopharmacology (Berl) 1995, 119:193-204.
24. Curry S.J., Wagner E.H., Grothaus L.C. Evaluation of intrinsic and extrinsic motivation interventions with a self-help smoking cessation program. J. Consult. Clin. Psychol. 1991, 59:318-324.
25. Dallery J., Glenn I.M. Effects of an Internet-based voucher reinforcement program for smoking abstinence: a feasibility study. J. Appl. Behav. Anal. 2005, 38:349-357.
26. Dallery J., Raiff B.R. Contingency management in the 21st century: technological innovations to promote smoking cessation. Subst. Use Misuse 2011, 46:10-22.
27. Dallery J., Silverman K., Chutuape M.A., Bigelow G.E., Stitzer M.L. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude. Exp. Clin. Psychopharmacol. 2001, 9:317-325.
28. Dallery J., Glenn I.M., Raiff B.R. An internet-based abstinence reinforcement treatment for cigarette smoking. Drug Alcohol Depend. 2007, 86:230-238.
29. Dallery J., Meredith S., Glenn I.M. A deposit contract method to deliver abstinence reinforcement for cigarette smoking. J. Appl. Behav. Anal. 2008, 41:609-615.
30. Donatelle R.J., Prows S.L., Champeau D., Hudson D. Randomized controlled trial using social support and financial incentives for high-risk pregnant smokers: significant other supporter (SOS) program. Tob. Control. 2000, 9:67-69.
31. Donatelle R., Hudson D., Dobie S., Goodall A., Hunsberger M., Oswald K. Incentives in smoking cessation: status of the field and implications for research and practice with pregnant smokers. Nicotine Tob. Res. 2004, 6:S163-S179.
32. Dunn K.E., Sigmon S.C., Thomas C.S., Heil S.H., Higgins S.T. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. J. Appl. Behav. Anal. 2008, 41:527-538.
33. Dunn K.E., Sigmon S.C., Reimann E.F., Badger G.J., Heil S.H., Higgins S.T. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Exp. Clin. Psychopharmacol. 2010, 18:37-50.
34. Eisenberg T., Stitzer M.L., Henningfield J.E. Current issues in nicotine replacement. Helping the Hard-Core Smoker: A Clinician's Guide 1999, 137-158. Lawrence Erlbaum Associates, Mahwah, NJ. D.F. Seidman, L.S. Covey (Eds.).
35. Elliott R., Tighe T. Breaking the cigarette habit: effects of a technique involving threatened loss of money. Psychol. Rec. 1968, 18:503-513.
36. Emery S., Gilpin E.A., Ake C.A., Farkas A.J., Pierce J.P. Characterizing and identifying "hard-core" smokers: implications for further reducing smoking prevalence. Am. J. Public Health 2000, 90:387-394.
37. Fagerstrom K.O., Kunze M., Schoberberger R., et al. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob. Control. 1996, 5:52-56.
38. Feil E.G., Noell J., Lichtenstein E., Boles S.M., McKay G.H. Evaluation of an Internet-based smoking cessation program: lessons learned from a pilot study. Nicotine Tob. Res. 2003, 5:189-194.
39. Fiore M.C., Smith S.S., Jorenby D.E., Baker T.B. The effectiveness of nicotine patch for smoking cessation: a meta-analysis. JAMA 1994, 271:1940-1947.
40. Fiore M.C., Jaén C.R., Baker T.B., et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline 2008, U.S. Department of Health and Human Services. Public Health Service, Rockville, MD.
41. Frosch D.L., Shoptaw S., Jarvik M.E., Rawson R.A., Ling W. Interest in smoking cessation among methadone maintained outpatients. J. Addict. Dis. 1998, 17:9-19.
42. Gaalema D.E., Higgins S.T., Bradstreet M.P., Heil S.H., Bernstein I.M. Using NicAlert strips to verify smoking status among pregnant cigarette smokers. Drug Alcohol Depend. 2011, 119:130-133.
43. Gadomski A., Adams L., Tallman N., Krupa N., Jenkins P. Effectiveness of a combined prenatal and postpartum smoking cessation program. Matern. Child Health J. 2011, 15:188-197.
44. Galbicka G. Shaping in the 21st century: moving percentile schedules into applied settings. J. Appl. Behav. Anal. 1994, 27:739-760.
45. Gallagher S.M., Penn P.E., Schindler E., Layne W. A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. J. Psychoactive Drugs 2007, 39:487-497.
46. Garvey A.J., Bliss R.E., Hitchcock J.L., Heinold J.W., Rosner B. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict. Behav. 1992, 17:367-377.
47. Glenn I.M., Dallery J. Effects of internet-based voucher reinforcement and a transdermal nicotine patch on cigarette smoking. J. Appl. Behav. Anal. 2007, 40:1-13.
48. GOLD Global Strategy for the Diagnosis, Management and Prevention of COPD 2010, Available from: http://www.goldcopd.org/.
49. Gourlay S.G., Forbes A., Marriner T., Pethica D., McNeil J.J. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. Br. Med. J. 1994, 309:842-846.
50. Graham H., Inskip H.M., Francis B., Harman J. Pathways of disadvantage and smoking careers: evidence and policy implications. J. Epidemiol. Community Health 2007, 60:ii7-ii12.
51. Gray K.M., Carpenter M.J., Baker N.L., et al. Bupropion SR and contingency management for adolescent smoking cessation. J. Subst. Abuse Treat. 2011, 40:77-86.
52. Hanson K., Allen S., Jensen S., Hatsukami D. Treatment of adolescent smokers with the nicotine patch. Nicotine Tob. Res. 2003, 5:515-526.
53. Heil S.H., Tidey J.W., Holmes H.W., Badger G.J., Higgins S.T. A contingent payment model of smoking cessation: effects of abstinence and withdrawal. Nicotine Tob. Res. 2003, 5:205-213.
54. Heil S.H., Alessi S.M., Lussier J.P., Badger G.J., Higgins S.T. An experimental test of the influence of prior cigarette smoking abstinence on future abstinence. Nicotine Tob. Res. 2004, 6:471-479.
55. Heil S.H., Higgins S.T., Bernstein I.M., et al. Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction 2008, 103:1009-1018.
56. Henningfield J.E. Tobacco dependence treatment: scientific challenges; public health opportunities. Tob. Control. 2000, 9:3-10.
57. Higgins S.T. Comments on contingency management and conditional cash transfers. Health Econ. 2010, 19:1255-1258.
58. Higgins S.T., Chilcoat H.D. Women and smoking: an interdisciplinary examination of socioeconomic influences. Drug Alcohol Depend. 2009, 104(Suppl. 1).
59. Higgins S.T., Delaney D.D., Budney A.J., et al. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiatry 1991, 148:1218-1224.
60. Higgins S.T., Budney A.J., Bickel W.K., Hughes J.R., Foerg F., Badger G. Achieving cocaine abstinence with a behavioral approach. Am. J. Psychiatry 1993, 150:763-769.
61. Higgins S.T., Heil S.H., Solomon L.J., et al. A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. Nicotine Tob. Res. 2004, 6:1015-1020.
62. Higgins S.T., Heil S.H., Dumeer A.M., Thomas C.S., Solomon L.J., Bernstein I.M. Smoking status in the initial weeks of quitting as a predictor of smoking-cessation outcomes in pregnant women. Drug Alcohol Depend. 2006, 85:138-141.
63. Higgins S.T., Heil S.H., Badger G.J., et al. Biochemical verification of smoking status in pregnant and recently postpartum women. Exp. Clin. Psychopharmacol. 2007, 15:58-66.
64. Higgins S.T., Heil S.H., Dantona R., Donham R., Matthews M., Badger G.J. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction 2007, 102:271-278.
65. Contingency Management in Substance Abuse Treatment 2008, The Guilford Press, New York, NY. S.T. Higgins, K. Silverman, S.H. Heil (Eds.).
66. Higgins S.T., Bernstein I.M., Washio Y., et al. Effects of smoking cessation with voucher-based contingency management on birth outcomes. Addiction 2010, 105:2023-2030.
67. Hser Y.I., McCarthy W.J., Anglin M.D. Tobacco use as a distal predictor of mortality among long-term narcotic addicts. Prev. Med. 1994, 23:61-69.
68. Hughes J.R., Gulliver S.B., Fenwick J.W., et al. Smoking cessation among self-quitters. Health Psychol. 1992, 11:331-334.
69. Hughes J.R., Keely J., Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004, 99:29-38.
70. Hunt Y.M., Rash Carla J., Burke Randy S., Parker Jefferson D. Smoking cessation in recovery: comparing 2 different cognitive behavioral treatments. Addict. Disord. Treat. 2010, 9:64-74.
71. Hurt R.D., Offord K.P., Croghan I.T., et al. Mortality following inpatient addictions treatment: role of tobacco use in a community-based cohort. JAMA 1996, 275:1097-1103.
72. Hurt R.D., Sachs D.P., Glover E.D., et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N. Engl. J. Med. 1997, 17:1195-1202.
73. Irons J.G., Correia C.J. A brief abstinence test for college student smokers: a feasibility study. Exp. Clin. Psychopharmacol. 2008, 16:223-229.
74. Jarvis M.J., Tunstall-Pedoe H., Feyerabend C., Vesey C., Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am. J. Public Health 1987, 77:1435-1438.
75. Javors M.A., Hatch J.P., Lamb R.J. Evaluation of cut-off levels for breath carbon monoxide as a marker for cigarette smoking over the past 24hours. Addiction 2005, 100:159-167.
76. Kaper J., Wagena E.J., Willemsen M.C., van Schayck C.P. Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction 2005, 100:1012-1020.
77. Kassaye W.W. Assessment of the impact of monetary incentives upon smoking behavior. J Drug Educ. 1984, 14:109-118.
78. Kenford S.L., Fiore M.C., Jorenby D.E., Smith S.S., Wetter D., Baker T.B. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA 1994, 271:589-594.
79. Ker M., Leischow S., Markowitz I.B., Merikle E. Involuntary smoking cessation: a treatment option in chemical dependency programs for women and children. J. Psychoactive Drugs 1996, 28:47-60.
80. Kirby K.C., Marlowe D.B., Festinger D.S., Lamb R.J., Platt J.J. Schedule of voucher delivery influences cocaine abstinence. J. Consult. Clin. Psychol. 1998, 66:761-767.
81. Knealing T.W., Roebuck M.C., Wong C.J., Silverman K. Economic cost of the therapeutic workplace intervention added to methadone maintenance. J. Subst. Abuse Treat. 2008, 34:326-332.
82. Kollins S.H., McClernon F.J., Van Voorhees E.E. Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD). Exp. Clin. Psychopharmacol. 2010, 18:221-228.
83. Kozlowski L.T., Skinner W., Kent C., Pope M.A. Prospects for smoking treatment in individuals seeking treatment for alcohol and other drug problems. Addict. Behav. 1989, 14:273-278.
84. Krishnan-Sarin S., Duhig A.M., McKee S., et al. Contingency management for smoking cessation in adolescent smokers. Exp. Clin. Psychopharmacol. 2006, 14:306-310.
85. Krishnan-Sarin S., Reynolds B., Duhig A.M., et al. Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend. 2007, 88:79-82.
86. Lamb R.J., Kirby K.C., Morral A.R., Galbicka G., Iguchi M.Y. Improving contingency management programs for addiction. Addict. Behav. 2004, 29:507-523.
87. Lamb R.J., Morral A.R., Kirby K.C., Iguchi M.Y., Galbicka G. Shaping smoking cessation using percentile schedules. Drug Alcohol Depend. 2004, 76:247-259.
88. Lamb R.J., Morral A.R., Galbicka G., Kirby K.C., Iguchi M.Y. Shaping reduced smoking in smokers without cessation plans. Exp. Clin. Psychopharmacol. 2005, 13:83-92.
89. Lamb R.J., Morral A.R., Kirby K.C., Javors M.A., Galbicka G., Iguchi M. Contingencies for change in complacent smokers. Exp. Clin. Psychopharmacol. 2007, 15:245-255.
90. Lando H.A. Successful treatment of smokers with a broad-spectrum behavioral approach. J. Consult. Clin. Psychol. 1977, 45:263-264.
91. Lando H.A., Pechacek T.F., Fruetel J. The Minnesota Heart Health Program community Quit and Win contests. Am. J. Health Promot. 1994, 9(85-87):124.
92. Ledgerwood D.M. Contingency management for smoking cessation: where do we go from here?. Curr. Drug Abuse Rev. 2008, 1:340-349.
93. Leeks K.D., Hopkins D.P., Soler R.E., Aten A., Chattopadhyay S.K. Worksite-based incentives and competitions to reduce tobacco use: a systematic review. Am. J. Prev. Med. 2010, 38:S263-S274.
94. Lussier J.P., Higgins S.T., Badger G.J. Influence of the duration of abstinence on the relative reinforcing effects of cigarette smoking. Psychopharmacology (Berl) 2005, 181:486-495.
95. Lussier J.P., Higgins S.T., Heil S.H., Badger G.J., Mongeon J. Voucher-based reinforcement therapy for substance use disorders: a quantitative review. Addiction 2006, 101:192-203.
96. Mannino D.M., Ford E.S., Redd S.C. Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination. Am. J. Med. 2003, 114:758-762.
97. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3:e442.
98. Meis T., Gaie M., Pingree S., et al. Development of a tailored, Internet-based smoking cessation intervention for adolescents. J. Comput.-Mediat. Commun. 2002, 7. 0-0.
99. Meredith S.E., Grabinski M.J., Dallery J. Internet-based group contingency management to promote abstinence from cigarette smoking: a feasibility study. Drug Alcohol Depend. 2011, 118:23-30.
100. Middleton E.T., Morice A.H. Breath carbon monoxide as an indication of smoking habit. Chest 2000, 117:758-763.
101. Mooney M., Babb D., Jensen J., Hatsukami D. Interventions to increase use of nicotine gum: a randomized, controlled, single-blind trial. Nicotine Tob. Res. 2005, 7:565-579.
102. Nahvi S., Richter K., Li X., Modali L., Arnsten J. Cigarette smoking and interest in quitting in methadone maintenance patients. Addict. Behav. 2006, 31:2127-2134.
103. NCCCC Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004, 59:S1-S232.
104. Norman C.D., McIntosh S., Selby P., Eysenbach G. Web-assisted tobacco interventions: empowering change in the global fight for the publics (e)health. J. Med. Internet Res. 2008, 10:e48.
105. Paxton R. The effects of a deposit contract as a component in a behavioral programme for stopping smoking. Behav. Res. Ther. 1980, 18:45-50.
106. Paxton R. Deposit contracts with smokers: varying frequency and amount of repayments. Behav. Res. Ther. 1981, 19:117-123.
107. Paxton R. Prolonging the effect of deposit contracts with smokers. Behav. Res. Ther. 1983, 21:425-433.
108. Pear, R., 2009. Congress plans incentives for healthy habits. New York Times. http://www.nytimes.com/2009/05/10/health/policy/10health.html?_r%205%201.
109. Perkins K.A., Lerman C., Stitzer M., et al. Development of procedures for early screening of smoking cessation medications in humans. Clin. Pharmacol. Ther. 2008, 84:216-221.
110. Perkins K.A., Lerman C., Fonte C.A., et al. Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clin. Pharmacol. Ther. 2010, 88:109-114.
111. Petry N.M., Alessi S.M. Lowering costs in drug abuse treatment clinics. Contingency Management in Substance Abuse Treatment 2008, 261-279. The Guilford Press, New York, NY. S.T. Higgins, K. Silverman, S.H. Heil (Eds.).
112. Petry N.M., Tedford J., Austin M., Nich C., Carroll K.M., Rounsaville B.J. Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?. Addiction 2004, 99:349-360.
113. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006, 101:1546-1560.
114. Public Health Service, U.S. Department of Health and Human Services Smoking Cessation: Clinical Practice Guideline 2000, Centers for Disease Control and Prevention, Washington, DC.
115. Ranney L., Melvin C., Lux L., McClain E., Lohr K.N. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann. Intern. Med. 2006, 145:845-856.
116. Rebagliato M. Validation of self-reported smoking. J. Epidemiol. Community Health 2002, 56:167-170.
117. Reynolds B., Dallery J., Shroff P., Patak M., Leraas K. A web-based contingency management program with adolescent smokers. J. Appl. Behav. Anal. 2008, 41:597-601.
118. Richter K.P., Gibson C.A., Ahluwalia J.S., Schmelzle K.H. Tobacco use and quit attempts among methadone maintenance clients. Am. J. Public Health 2001, 91:296-299.
119. Riley W., Jerome A., Behar A., Weil J. Computer and manual self-help behavioral strategies for smoking reduction: initial feasibility and one-year follow-up. Nicotine Tob. Res. 2002, 4:S183-S188.
120. Robles E., Crone C.C., Whiteside-Mansell L., et al. Voucher-based incentives for cigarette smoking reduction in a women's residential treatment program. Nicotine Tob. Res. 2005, 7:111-117.
121. Roll J.M. Assessing the feasibility of using contingency management to modify cigarette smoking by adolescents. J. Appl. Behav. Anal. 2005, 38:463-467.
122. Roll J.M., Higgins S.T. A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Drug Alcohol Depend. 2000, 58:103-109.
123. Roll J.M., Howard J.T. The relative contribution of economic valence to contingency management efficacy: a pilot study. J. Appl. Behav. Anal. 2008, 41:629-633.
124. Roll J.M., Higgins S.T., Badger G.J. An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J. Appl. Behav. Anal. 1996, 29:495-505.
125. Roll J.M., Higgins S.T., Steingard S., McGinley M. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study. Exp. Clin. Psychopharmacol. 1998, 6:157-161.
126. Roll J.M., Reilly M.P., Johanson C.E. The influence of exchange delays on cigarette versus money choice: a laboratory analog of voucher-based reinforcement therapy. Exp. Clin. Psychopharmacol. 2000, 8:366-370.
127. Roll J.M., Chudzynski J.E., Richardson G. Potential sources of reinforcement and punishment in a drug-free treatment clinic: client and staff perceptions. Am. J. Drug Alcohol Abuse 2005, 31:21-33.
128. Rosenberg, T. 2008. A payoff out of poverty? NY Times Magazine. http://www.nytimes.com/2008/12/21/magazine/21cash-t.html?_r%2051.
129. Schmitz J.M., Rhoades H., Grabowski J. Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients. Addict. Behav. 1995, 20:171-179.
130. Sees K.L., Clark H.W. When to begin smoking cessation in substance abusers. J. Subst. Abuse Treat. 1993, 10:189-195.
131. Seidman D.F., Covey L.S. Helping the Hard-Core Smoker: A Clinician's Guide 1999, Lawrence Erlbaum Associates, Mahwah, NJ.
132. Shoptaw S., Jarvik M.E., Ling W., Rawson R.A. Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict. Behav. 1996, 21:409-412.
133. Shoptaw S., Rotheram-Fuller E., Yang X., et al. Smoking cessation in methadone maintenance. Addiction 2002, 97:1317-1328.
134. Silverman K., Higgins S.T., Brooner R.K., et al. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch. Gen. Psychiatry 1996, 53:409-415.
135. Silverman K., Chutuape M.A., Bigelow G.E., Stitzer M.L. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacology (Berl) 1999, 146:128-138.
136. Silverman K., Wong C.J., Needham M., et al. A randomized trial of employment-based reinforcement of cocaine abstinence in injection drug users. J. Appl. Behav. Anal. 2007, 40:387-410.
137. Spring F.L.S., James F., Trimble Ralph W., Goeckner Daniel J. Effects of contingency and noncontingency contracts in the context of a self-control-oriented smoking modification program. Behav. Ther. 1978, 9:967-968.
138. SRNT Subcommittee on Biochemical Verification Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 2002, 4:149-159.
139. Stanger C., Budney A.J. Contingency management approaches for adolescent substance use disorders. Child Adolesc. Psychiatr. Clin. N. Am. 2010, 19:547-562.
140. Stitzer M.L. Combined behavioral and pharmacological treatments for smoking cessation. Nicotine Tob. Res. 1999, 1:S181-S187.
141. Stitzer M.L., Bigelow G.E. Contingent reinforcement for reduced carbon monoxide levels in cigarette smokers. Addict. Behav. 1982, 7:403-412.
142. Stitzer M.L., Bigelow G.E. Contingent payment for carbon monoxide reduction: effects of pay amount. Behav. Ther. 1983, 14:647-656.
143. Stitzer M.L., Bigelow G.E. Contingent reinforcement for carbon monoxide reduction: within-subject effects of pay amount. J. Appl. Behav. Anal. 1984, 17:477-483.
144. Stitzer M.L., Bigelow G.E. Contingent reinforcement for carbon monoxide reduction: target-specific effects on cigarette smoking. Addict. Behav. 1985, 10:345-349.
145. Stitzer M.L., Kellogg S. Large-scale dissemination efforts in drug abuse treatment clinics. Contingency Management in Substance Abuse Treatment 2008, 241-260. The Guilford Press, New York, NY. S.T. Higgins, K. Silverman, S.H. Heil (Eds.).
146. Stitzer M.L., Bigelow G.E., Lawrence C., Cohen J., D'Lugoff B., Hawthorne J. Medication take-home as a reinforcer in a methadone maintenance program. Addict. Behav. 1977, 2:9-14.
147. Stitzer M.L., Bickel W.K., Bigelow G.E., Liebson I.A. Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients. Drug Alcohol Depend. 1986, 18:341-348.
148. Stitzer M.L., Rand C.S., Bigelow G.E., Mead A.M. Contingent payment procedures for smoking reduction and cessation. J. Appl. Behav. Anal. 1986, 19:197-202.
149. Stoops W.W., Dallery J., Fields N.M., et al. An internet-based abstinence reinforcement smoking cessation intervention in rural smokers. Drug Alcohol Depend. 2009, 105:56-62.
150. Tevyaw T.O.L., Gwaltney C., Tidey J.W., et al. Contingency management for adolescent smokers: an exploratory study. J. Child Adolesc. Subst. Abuse 2007, 16:23-44.
151. Tevyaw T.O., Colby S.M., Tidey J.W., et al. Contingency management and motivational enhancement: a randomized clinical trial for college student smokers. Nicotine Tob. Res. 2009, 11:739-749.
152. Tidey J.W., O'Neill S.C., Higgins S.T. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Exp. Clin. Psychopharmacol. 2002, 10:241-247.
153. Tidey J.W., Rohsenow D.J., Kaplan G.B., Swift R.M., Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology (Berl) 2011, 217:279-287.
154. U.S. Department of Health and Human Services The health consequences of smoking: chronic obstructive lung disease. A Report of the Surgeon General 1984, U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health, Rockville (MD), DHHS Publication No. (PHS) 84-50205.
155. U.S. Department of Health and Human Services The Health Consequences of Smoking: A Report of the Surgeon General 2004, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
156. van Weel C., Schellevis F.G. Comorbidity and guidelines: conflicting interests. Lancet 2006, 367:550-551.
157. Volpp K.G., Levy A.G., Asch D.A., et al. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol. Biomarkers Prev. 2006, 15:12-18.
158. Volpp K.G., Troxel A.B., Pauly M.V., et al. A randomized, controlled trial of financial incentives for smoking cessation. N. Engl. J. Med. 2009, 360:699-709.
159. White H.D. Scientific communication and literature retrieval. The Handbook of Research Synthesis 1994, 41-55. Russell Sage Foundation, New York, NY, US.
160. Winett R.A. Parameters of deposit contracts in the modification of smoking. Psychol. Rec. 1973, 23:49-60.
161. Wiseman E.J., Williams D.K., McMillan D.E. Effectiveness of payment for reduced carbon monoxide levels and noncontingent payments on smoking behaviors in cocaine-abusing outpatients wearing nicotine or placebo patches. Exp. Clin. Psychopharmacol. 2005, 13:102-110.
162. Woodruff S.I., Edwards C.C., Conway T.L., Elliot S.P. Pilot test of an internet virtual world chat room for rural teen smokers. J. Adolesc. Health 2001, 29:239-243.
163. Yoon J.H., Higgins S.T., Bradstreet M.P., Badger G.J., Thomas C.S. Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence. Psychopharmacology 2009, 205:305-318.
164. Yudkin P.L., Jones L., Lancaster T., Fowler G.H. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Br. J. Gen. Pract. 1996, 46:145-148.